DEXCOM, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
DEXCOM, INC. (DXCM) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of 1.50% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-12
- DEXCOM, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was 1.50%.
- DEXCOM, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2015 was 5.37%, a 66.29% decline from fiscal 2014.
- DEXCOM, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2014 was 15.93%, a 614.35% increase from fiscal 2013.
- DEXCOM, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2013 was 2.23%, a 25.91% decline from fiscal 2012.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.50% 10-K · filed 2026-02-12 | |
| 2015-12-31 | 5.37% 10-K · filed 2016-02-23 | |
| 2014-12-31 | 15.93% 10-K · filed 2016-02-23 | |
| 2013-12-31 | 2.23% 10-K · filed 2016-02-23 | -2.23% 10-K · filed 2014-02-20 |
| 2012-12-31 | 3.01% 10-K · filed 2015-02-25 | -3.01% 10-K · filed 2013-02-21 |
| 2011-12-31 | -2.37% 10-K · filed 2014-02-20 | |
| 2010-12-31 | -2.39% 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |